Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Pfizer, Inc.
EIR
•Pfizer, Inc.•April 19, 2023

Pfizer, Inc. – FDA EIR, Apr 19, 2023

Record Details

Pfizer, Inc. underwent an FDA Establishment Inspection at its Groton, CT facility from April 11 to April 19, 2023. This was a mission-critical, high-priority PDUFA surveillance inspection for a sponsor of human clinical trials, conducted under Good Clinical Practice guidelines and Compliance Program 7348.810 for Sponsors and Contract Research Organizations. The inspection focused on a specific clinical study supporting a Biologics License Application (BLA) and an Investigational New Drug (IND). Key areas reviewed included ClinicalTrials.gov compliance, site training, safety monitoring, investigational product control, financial disclosures, and oversight of eight selected clinical sites. While the overall inspection concluded without the issuance of a Form FDA 483, indicating no objectionable conditions requiring immediate regulatory action, the report highlighted repeated instances of source data inaccuracies, CRF data entry discrepancies, and non-compliance with Pfizer procedures at a specific clinical site (site 1102). In response to these internal findings, Pfizer and its Contract Research Organization partners initiated an audit, increased monitoring, retrained the clinical investigator, and implemented a remediation plan for the affected site. No specific regulatory actions were mandated by the FDA at the conclusion of this inspection.

Company
Pfizer, Inc.
Inspection date
April 19, 2023
Product type
biologics
Office
Center for Drug Evaluation and Research
Person
  • Gabrielle J. Swain (investigator)
View Company Profile

ID · cf3a8a77-b238-4293-b06b-75cfecbed946

Violation Codes2
21 CFR 1121 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Pfizer, Inc.
  • 483 - 2017-06-28June 28, 2017
  • 483 - 2017-06-07June 7, 2017
  • EIR - 2014-12-05December 5, 2014
  • 483 - 2012-02-24February 24, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pfizer, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.